Halozyme Therapeutics (HALO) News Today $73.38 -1.44 (-1.92%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Halozyme Therapeutics Down Today?Toggle Visibility of Why Is Halozyme Therapeutics Down Today?Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock has been supported by a series of bullish analyst actions and technical breakouts, though an insider sale may warrant monitoring. Key developments include: Positive Sentiment: Halozyme reached a new 52-week high on elevated trading momentum. Halozyme Therapeutics (NASDAQ:HALO) Hits New 52-Week High Positive Sentiment: Picked as one of four PEG-rated GARP stocks offering both value and growth potential. 4 PEG-Rated GARP Stocks That Offer Both Value and Growth Positive Sentiment: Zacks Research upgraded HALO from “hold” to “strong-buy,” reflecting increased conviction. Zacks.com Positive Sentiment: Zacks Research raised its Q2 2026 EPS forecast to $1.24 and reiterated its “strong-buy” rating. Free Report Positive Sentiment: Highlighted as a top momentum pick for growth-oriented traders. Are You Looking for a Top Momentum Pick? Positive Sentiment: Ranked Zacks #1 (strong-buy) momentum stock on September 3rd. Best Momentum Stock to Buy for September 3rd Positive Sentiment: Added to Zacks Rank #1 (strong-buy) list on September 3rd alongside peers. New Strong Buy Stocks for September 3rd Neutral Sentiment: Analysis of HALO’s year-to-date performance versus sector peers highlights relative strength. Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? Neutral Sentiment: Reached a 52-week high, prompting questions about sustainable upside based on fundamentals. Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue? Negative Sentiment: Company director Bernadette Connaughton sold 4,000 shares, reducing her ownership by 7.85%. Bernadette Connaughton Sells 4,000 Shares of HALO Posted 1h agoAI Generated. May Contain Errors. HALO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Halozyme Therapeutics (NASDAQ:HALO) Hits New 52-Week High - Here's What Happened3 hours ago | marketbeat.comPDT Partners LLC Grows Position in Halozyme Therapeutics, Inc. $HALOSeptember 3 at 8:05 AM | marketbeat.comPinnacle Wealth Planning Services Inc. Takes Position in Halozyme Therapeutics, Inc. $HALOSeptember 3 at 5:53 AM | marketbeat.comBernadette Connaughton Sells 4,000 Shares of Halozyme Therapeutics (NASDAQ:HALO) StockSeptember 3 at 4:23 AM | insidertrades.comSteamboat Capital Partners LLC Has $9.57 Million Position in Halozyme Therapeutics, Inc. $HALOSeptember 2 at 8:34 AM | marketbeat.comWellington Management Group LLP Decreases Stock Holdings in Halozyme Therapeutics, Inc. $HALOSeptember 1 at 3:52 AM | marketbeat.comRafferty Asset Management LLC Sells 106,103 Shares of Halozyme Therapeutics, Inc. $HALOAugust 30, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (HALO) Hikes 2025 Guidance on ENHANZE DemandAugust 29, 2025 | finance.yahoo.comEpoch Investment Partners Inc. Acquires 48,936 Shares of Halozyme Therapeutics, Inc. $HALOAugust 29, 2025 | marketbeat.comFORA Capital LLC Takes Position in Halozyme Therapeutics, Inc. $HALOAugust 29, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Sold by Corebridge Financial Inc.August 29, 2025 | marketbeat.comRaymond James Financial Inc. Decreases Stock Position in Halozyme Therapeutics, Inc. $HALOAugust 29, 2025 | marketbeat.comMorgan Stanley Raises PT on Halozyme Therapeutics (HALO) to $80 From $75August 29, 2025 | finance.yahoo.comMorgan Stanley Raises PT on Halozyme Therapeutics (HALO), After Q2 ResultsAugust 29, 2025 | finance.yahoo.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Receives $67.11 Consensus Price Target from AnalystsAugust 29, 2025 | americanbankingnews.comHalozyme to Participate at Upcoming Investor ConferencesAugust 28, 2025 | prnewswire.comCaisse DE Depot ET Placement DU Quebec Grows Position in Halozyme Therapeutics, Inc. $HALOAugust 28, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Reduces Holdings in Halozyme Therapeutics, Inc. $HALOAugust 28, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Reaches New 12-Month High - What's Next?August 27, 2025 | marketbeat.comIs New CMS Drug Pricing Guidance Changing the Long-Term Growth Outlook for Halozyme Therapeutics (HALO)?August 27, 2025 | finance.yahoo.comMetLife Investment Management LLC Increases Stock Holdings in Halozyme Therapeutics, Inc. $HALOAugust 27, 2025 | marketbeat.comHighTower Advisors LLC Has $1.56 Million Stock Position in Halozyme Therapeutics, Inc. $HALOAugust 27, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Hold" by BrokeragesAugust 27, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Bought by Campbell & CO Investment Adviser LLCAugust 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Purchased by Oliver Luxxe Assets LLCAugust 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Acquired by Credit Agricole S AAugust 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Sold by Northern Trust CorpAugust 26, 2025 | marketbeat.comHalozyme Therapeutics, Inc. $HALO Shares Acquired by Advantage Alpha Capital Partners LPAugust 24, 2025 | marketbeat.comCW Advisors LLC Boosts Stake in Halozyme Therapeutics, Inc. $HALOAugust 24, 2025 | marketbeat.comDimensional Fund Advisors LP Purchases 95,600 Shares of Halozyme Therapeutics, Inc. $HALOAugust 24, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Has $2.69 Million Stock Position in Halozyme Therapeutics, Inc. $HALOAugust 23, 2025 | marketbeat.comAberdeen Group plc Sells 21,933 Shares of Halozyme Therapeutics, Inc. $HALOAugust 23, 2025 | marketbeat.comBiotech Leader Rallies To Highs As Funds Load UpAugust 22, 2025 | msn.comAmerican Century Companies Inc. Buys 29,046 Shares of Halozyme Therapeutics, Inc. $HALOAugust 22, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Sets New 12-Month High After Analyst UpgradeAugust 21, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Has $23.83 Million Stake in Halozyme Therapeutics, Inc. $HALOAugust 21, 2025 | marketbeat.comFuller & Thaler Asset Management Inc. Acquires 242,167 Shares of Halozyme Therapeutics, Inc. $HALOAugust 21, 2025 | marketbeat.comHalozyme Therapeutics (NASDAQ:HALO) Stock Price Expected to Rise, Morgan Stanley Analyst SaysAugust 20, 2025 | marketbeat.comBrandywine Global Investment Management LLC Makes New $4.76 Million Investment in Halozyme Therapeutics, Inc. $HALOAugust 20, 2025 | marketbeat.comWhat 7 Analyst Ratings Have To Say About Halozyme TherapeuticsAugust 19, 2025 | benzinga.comCresset Asset Management LLC Has $19.55 Million Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)August 19, 2025 | marketbeat.comTravere Therapeutics Reaches 80-Plus Relative Strength Rating BenchmarkAugust 18, 2025 | msn.comKymera Therapeutics Shows Market Leadership With Jump To 84 RS RatingAugust 18, 2025 | msn.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Boston PartnersAugust 17, 2025 | marketbeat.comMineralys Therapeutics Scores Relative Strength Rating Upgrade; Hits Key BenchmarkAugust 15, 2025 | msn.comInsider Selling: Halozyme Therapeutics, Inc. (NASDAQ:HALO) CEO Sells 20,000 Shares of StockAugust 15, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by E Fund Management Co. Ltd.August 15, 2025 | marketbeat.comHalozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Bought by Prudential PLCAugust 15, 2025 | marketbeat.comVirtu Financial LLC Has $880,000 Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)August 14, 2025 | marketbeat.comEntropy Technologies LP Buys Shares of 11,452 Halozyme Therapeutics, Inc. (NASDAQ:HALO)August 14, 2025 | marketbeat.com Get Halozyme Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HALO Media Mentions By Week HALO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HALO News Sentiment▼0.980.69▲Average Medical News Sentiment HALO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HALO Articles This Week▼1814▲HALO Articles Average Week Get the Latest News and Ratings for HALO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIIB News Today INCY News Today NBIX News Today UTHR News Today BMRN News Today EXEL News Today MDGL News Today EXAS News Today RGEN News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HALO) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HALO Stock Alerts